🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.1680
-0.0160 (-8.70%)
Nov 20, 2026, 4:00 PM EST - Market closed

IGC Pharma Revenue

IGC Pharma had revenue of $328.00K in the quarter ending September 30, 2026. This brings the company's total for the last twelve months to $1.11M, down -6.51% year-over-year. In the fiscal year ending March 31, 2025, IGC Pharma had annual revenue of $1.27M, down -5.50%. That makes IGC Pharma the 43,475th largest company in the world by revenue and 6,060th in the United States.

Revenue (ttm)
$1.11M
Revenue Growth
-6.51%
P/S Ratio
17.72
Revenue / Employee
$15,800
Employees
70
Market Cap
19.60M

Revenue Chart

Revenue by Geography

  • United States of America 1.27M 99.8%
  • Colombia 2.00K 0.2%
Fiscal year ended Mar 31, 2025 See the full IGC Pharma breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20251.27M-74.00K-5.50%
Mar 31, 20241.35M434.00K47.64%
Mar 31, 2023911.00K514.00K129.47%
Mar 31, 2022397.00K-501.00K-55.79%
Mar 31, 2021898.00K-3.17M-77.95%
Mar 31, 20204.07M-1.04M-20.41%
Mar 31, 20195.12M2.92M133.29%
Mar 31, 20182.19M1.61M277.86%
Mar 31, 2017580.37K-5.79M-90.88%
Mar 31, 20166.37M-1.31M-17.10%
Mar 31, 20157.68M5.41M237.87%
Mar 31, 20142.27M-5.76M-71.69%
Mar 31, 20138.03M3.83M91.21%
Mar 31, 20124.20M125.63K3.08%
Mar 31, 20114.07M-13.82M-77.24%
Mar 31, 201017.90M-17.44M-49.35%
Mar 31, 200935.34M33.15M1,515.10%
Mar 31, 20082.19M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Evaxion7.49M
Metagenomi Therapeutics7.09M
Marker Therapeutics2.31M
ABVC BioPharma797.92K
CervoMed8.73K
Revenue Rankings